Cancer drug seen to reduce HIV cells in patient for 1st time
France-based doctors have reported the first case of depletion of HIV-infected cells in a 51-year-old undergoing lung cancer treatment. After doctors injected a cancer drug nivolumab, they observed a sustained drop in HIV reservoirs with increased activity of T-cells signalling a boost in immunity. The doctors, however, urged caution as they didn't observe the same effect in another HIV patient.